Navigation Links
Antibiotics for acute uncomplicated lower respiratory tract infection

According to the article published in The Journal of the American Medical Association, no offer or delayed offer of antibiotics for // acute uncomplicated lower respiratory tract infection (LRTI) is acceptable. Acute lower respiratory tract infection is a common complaint in the out patient departments and is one of the most common condition which is treated.

The randomized controlled trial was undertaken to assess the effectiveness on symptoms, beliefs, and behavior of three different antibiotic prescribing strategies and to assess the effectiveness of an information leaflet compared with brief verbal information alone. 807 patients who presented to the primary care setting between 1998 and 2003 with acute uncomplicated lower respiratory tract infection (LRTI) were randomly allocated into one of the six groups consisting of leaflet or no leaflet in the groups- immediate antibiotics, no offer of antibiotics, and delayed antibiotics. The outcome of the trial was measured in terms of symptom duration and severity. Seventy percent of them returned completed diaries and about 10% provided information on the symptom duration and severity. Cough rated as at least "a slight problem" lasted a mean of 11.7 days.

The results of the trial showed that the information leaflet had no effect on the main outcomes. Compared with no offer of antibiotics, other strategies did not alter cough duration or other primary outcomes. Compared with the group for whom immediate antibiotics were prescribed, fewer patients in the delayed and control groups used antibiotics, fewer patients were "very satisfied” and fewer patients believed in the effectiveness of antibiotics. The study concluded that no or a delayed offer of antibiotics for acute uncomplicated lower respiratory tract infection is quite acceptable. It was also associated with little difference in symptom resolution and is likely to reduce antibiotic use and beliefs in the effectiveness of antibiotics.
LRTI being a seasonal and a common problem encountered in individuals and especially in the children, the present study reveals some interesting findings in terms of antibiotic use and abuse.

Description According to the article published in The Journal of the American Medical Association, no offer or delayed offer of antibiotics for acute uncomplicated lower respiratory tract infection (LRTI) is acceptable.
'"/>




Related medicine news :

1. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
2. Antibiotics Helps Autism
3. Antibiotics losing their power against acne
4. Antibiotics help heart patients
5. Antibiotics May Help Prevent Strokes
6. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
7. Antibiotics Overload For Kids Questioned
8. The Use Of Antibiotics Questioned
9. The Dangers Of Prescribing Antibiotics
10. Eliminating Eye Infection With Antibiotics
11. Eliminating Eye Infection With Antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite ... program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, ... In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the ... have extremely low property-tax rates, which contributes to the relatively lower cost of ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... ... Cal Dining at the University of California Berkeley, and other leading institutions in ... the buying power of institutions to change the way animals are raised for ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... manufacturer, has expanded its executive staff with the addition of industry sales leader, ... role, Slott will develop the national distribution and sales network, direct the efforts ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology: